Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huiru Guo

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Frontiers in Oncology|February 21, 2022
Clinical and Biological Interpretation of Survival Curves of Cancer Patients, Exemplified With Stage IV Non-Small Cell Lung Cancers With Long Follow-upJan P A Baak, Hegen Li, Huiru Guo
Integrative Cancer Therapies|August 25, 2011
Is the improvement of prognosis of patients with metastatic pulmonary adenocarcinoma treated with TCM herbal medicine due to lag time to treatment bias?Huiru Guo, Luming Liu, Jan P A Baak
Frontiers in Oncology|July 10, 2026
Body mass index and fasting insulin predict survival and EGFR-TKI benefit in Stage IV lung adenocarcinomaHuiru Guo, Lingshuang Liu, Jan P A Baak
The Analyst|October 11, 2021
Dual-targeting SERS-encoded graphene oxide nanocarrier for intracellular co-delivery of doxorubicin and 9-aminoacridine with enhanced combination therapyHui Chen, Longqiang Xing, Huiru Guo, et al.
Frontiers in Pharmacology|August 4, 2017
In Metastatic Non-small cell Lung Cancer Platinum-Based Treated Patients, Herbal Treatment Improves the Quality of Life. A Prospective Randomized Controlled Clinical TrialHuiru Guo, Jia X Liu, Hegen Li, et al.
Chemistry, an Asian Journal|April 22, 2025
Magnetically Driven Hydrogel Microrobots for Targeted Antibiotic DeliveryBinjie Chen, Shuming Zhang, Huiru Guo, et al.
Integrative Cancer Therapies|December 15, 2010
Traditional Chinese medicine herbal treatment may have a relevant impact on the prognosis of patients with stage IV adenocarcinoma of the lung treated with platinum-based chemotherapy or combined targeted therapy and chemotherapyHuiru Guo, Jia Xiang Liu, Ling Xu, et al.
Frontiers in Oncology|January 7, 2022
"How Long Have I Got?" in Stage IV NSCLC Patients With at Least 3 Months Up to 10 Years Survival, Accuracy of Long-, Intermediate-, and Short-Term Survival Prediction Is Not Good Enough to Answer This QuestionHuiru Guo, Hegen Li, Lihua Zhu, et al.
Integrative Cancer Therapies|September 28, 2011
Prognostic proof and possible therapeutic mechanisms of herbal medicine in patients with metastatic lung and colon cancerJan P A A Baak, Charlotte Gyllenhaal, Luming Liu, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|October 13, 2023
In stage IV pulmonary adenocarcinoma patients, treatment with Traditional Chinese Medicine alone gives prognostically superior results to treatment with Platinum-Based Chemotherapy aloneHuiru Guo, Hegen Li, Lihua Zhu, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Frontiers in Oncology|February 21, 2022
Clinical and Biological Interpretation of Survival Curves of Cancer Patients, Exemplified With Stage IV Non-Small Cell Lung Cancers With Long Follow-upJan P A Baak, Hegen Li, Huiru Guo
Integrative Cancer Therapies|August 25, 2011
Is the improvement of prognosis of patients with metastatic pulmonary adenocarcinoma treated with TCM herbal medicine due to lag time to treatment bias?Huiru Guo, Luming Liu, Jan P A Baak
Frontiers in Oncology|July 10, 2026
Body mass index and fasting insulin predict survival and EGFR-TKI benefit in Stage IV lung adenocarcinomaHuiru Guo, Lingshuang Liu, Jan P A Baak
The Analyst|October 11, 2021
Dual-targeting SERS-encoded graphene oxide nanocarrier for intracellular co-delivery of doxorubicin and 9-aminoacridine with enhanced combination therapyHui Chen, Longqiang Xing, Huiru Guo, et al.
Frontiers in Pharmacology|August 4, 2017
In Metastatic Non-small cell Lung Cancer Platinum-Based Treated Patients, Herbal Treatment Improves the Quality of Life. A Prospective Randomized Controlled Clinical TrialHuiru Guo, Jia X Liu, Hegen Li, et al.
Chemistry, an Asian Journal|April 22, 2025
Magnetically Driven Hydrogel Microrobots for Targeted Antibiotic DeliveryBinjie Chen, Shuming Zhang, Huiru Guo, et al.
Integrative Cancer Therapies|December 15, 2010
Traditional Chinese medicine herbal treatment may have a relevant impact on the prognosis of patients with stage IV adenocarcinoma of the lung treated with platinum-based chemotherapy or combined targeted therapy and chemotherapyHuiru Guo, Jia Xiang Liu, Ling Xu, et al.
Frontiers in Oncology|January 7, 2022
"How Long Have I Got?" in Stage IV NSCLC Patients With at Least 3 Months Up to 10 Years Survival, Accuracy of Long-, Intermediate-, and Short-Term Survival Prediction Is Not Good Enough to Answer This QuestionHuiru Guo, Hegen Li, Lihua Zhu, et al.
Integrative Cancer Therapies|September 28, 2011
Prognostic proof and possible therapeutic mechanisms of herbal medicine in patients with metastatic lung and colon cancerJan P A A Baak, Charlotte Gyllenhaal, Luming Liu, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|October 13, 2023
In stage IV pulmonary adenocarcinoma patients, treatment with Traditional Chinese Medicine alone gives prognostically superior results to treatment with Platinum-Based Chemotherapy aloneHuiru Guo, Hegen Li, Lihua Zhu, et al.
Pageof 2